Clinical Trial Update: Efficacy Study of an Anti-Tumor Necrosis Factor (TNF) Alpha Agent in Patients With Hand Osteoarthritis [Phase 3]

View source ↗

Summary

A Phase 3 efficacy trial evaluating an anti-TNF alpha agent in hand osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Osteoarthritis

Drugs mentioned

• Anti-TNF alpha agent (unspecified)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Hand Osteoarthritis | Phase 3 | Status: COMPLETED